Transgene

Transgene Inventory

Inventory of Transgene (TNG.PA) as of Oct 8, 2026.

Inventory

0.00EUR

Last updated:

Inventory of Transgene is 2019 0.00 EUR. Inventory of Transgene was 2018 443,000.00 EUR. It decreases by % lower compared to the previous year.

The Transgene Inventory history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Inventory
Date
Inventory
Jan 1, 2014
1.15 M EUR
Jan 1, 2015
1.16 M EUR
Jan 1, 2016
221,000.00 EUR
Jan 1, 2017
270,000.00 EUR
Jan 1, 2018
443,000.00 EUR
Jan 1, 2019
0.00 EUR
The Transgene Inventory history
YEARInventoryYoY
0.00EUR-100.00%
443,000.00EUR+64.07%
270,000.00EUR+22.17%
221,000.00EUR-81.01%
1.16 MEUR+1.31%
1.15 MEUR—
Access this data via the Eulerpool API
Get Free API Key

Transgene Stock analysis

What does Transgene do? Transgene SA is a French biotechnology company specializing in the development and production of therapeutics, with a focus on cancer medications. It has a strong patent portfolio in the field of viral vectors, which are used for targeted gene therapy. The company's main areas of operation are clinical trials, research, and production. Transgene has research and production facilities in Strasbourg and Lyon, with over 100 employees. It has established partnerships with pharmaceutical companies, including Takeda Pharmaceuticals, for the development and marketing of therapeutics. Its flagship product, OncoVir-1®, is an immunomodulator that stimulates the immune system to fight tumor cells. Another promising product is TG4010, a therapeutic vaccine for non-small cell lung carcinoma. Transgene is an emerging company with a promising portfolio of cancer therapeutics, leveraging its expertise in viral vectors and collaborating closely with industry partners to expedite the development of marketable products. Transgene is expected to play a significant role in the development of new and innovative cancer treatments. Transgene is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Transgene stock

On Eulerpool you can find the complete historical development of Inventory Transgene since 2006 – with annual values, charts, and detailed analysis.

Inventory includes raw materials, work-in-progress, and finished goods. Efficient inventory management is crucial for profitability.

Inventory's EUR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Inventory's Transgene historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Balance Sheet — Transgene

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Transgene